Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
iopamidol
- Development stage
- Approved
- Lead developer
- Bracco Diagnostics
- Modality
- Small Molecules
- Administration
- Intravenous, Intrathecal, Oral, Rectal, Intra-arterial
01
Overview
Iopamidol is a nonionic, water-soluble, low-osmolality iodinated radiographic contrast medium. Developed by **Bracco**, it is widely utilized in diagnostic imaging procedures such as computed tomography (CT), angiography, and urography. The drug works by absorbing X-rays as they pass through the body, thereby enhancing the visibility of blood vessels, organs, and lymphatic structures. It is particularly noted for its improved safety profile and lower risk of contrast-induced nephrotoxicity compared to older ionic, high-osmolality agents. Clinical applications include sentinel lymph node mapping in breast cancer, coronary angiography, and peripheral vascular imaging.
- Brand names
- IsovueIopamironIopamiroScanluxGastromiro
- Other names
- iopamidolumN,N'-bis(1,3-dihydroxypropan-2-yl)-5-[(2S)-2-hydroxypropanamido]-2,4,6-triiodoisophthalamide
Beyond the preview
Go deeper on iopamidol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on iopamidol.